210 related articles for article (PubMed ID: 8962143)
21. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms.
Golub TR; Barker GF; Stegmaier K; Gilliland DG
Curr Top Microbiol Immunol; 1997; 220():67-79. PubMed ID: 9103676
[No Abstract] [Full Text] [Related]
22. Haemopoietic transformation by the TEL/ABL oncogene.
Hannemann JR; McManus DM; Kabarowski JH; Wiedemann LM
Br J Haematol; 1998 Jul; 102(2):475-85. PubMed ID: 9695962
[TBL] [Abstract][Full Text] [Related]
23. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).
Wlodarska I; Mecucci C; Marynen P; Guo C; Franckx D; La Starza R; Aventin A; Bosly A; Martelli MF; Cassiman JJ
Blood; 1995 May; 85(10):2848-52. PubMed ID: 7742547
[TBL] [Abstract][Full Text] [Related]
24. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub TR; Barker GF; Bohlander SK; Hiebert SW; Ward DC; Bray-Ward P; Morgan E; Raimondi SC; Rowley JD; Gilliland DG
Proc Natl Acad Sci U S A; 1995 May; 92(11):4917-21. PubMed ID: 7761424
[TBL] [Abstract][Full Text] [Related]
25. Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms.
Golub TR; Barker GF; Stegmaier K; Gilliland DG
Curr Top Microbiol Immunol; 1996; 211():279-88. PubMed ID: 8585959
[No Abstract] [Full Text] [Related]
26. The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity.
Buijs A; van Rompaey L; Molijn AC; Davis JN; Vertegaal AC; Potter MD; Adams C; van Baal S; Zwarthoff EC; Roussel MF; Grosveld GC
Mol Cell Biol; 2000 Dec; 20(24):9281-93. PubMed ID: 11094079
[TBL] [Abstract][Full Text] [Related]
27. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
Okuda K; Golub TR; Gilliland DG; Griffin JD
Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688
[TBL] [Abstract][Full Text] [Related]
28. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9.
Chakrabarti SR; Sood R; Ganguly S; Bohlander S; Shen Z; Nucifora G
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7467-72. PubMed ID: 10377438
[TBL] [Abstract][Full Text] [Related]
29. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A.
Chakrabarti SR; Nucifora G
Biochem Biophys Res Commun; 1999 Nov; 264(3):871-7. PubMed ID: 10544023
[TBL] [Abstract][Full Text] [Related]
30. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
[TBL] [Abstract][Full Text] [Related]
31. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells.
Monni R; Santos SC; Mauchauffe M; Berger R; Ghysdael J; Gouilleux F; Gisselbrecht S; Bernard O; Penard-Lacronique V
Oncogene; 2001 Feb; 20(7):849-58. PubMed ID: 11314018
[TBL] [Abstract][Full Text] [Related]
32. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
[TBL] [Abstract][Full Text] [Related]
33. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
34. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).
Ross TS; Bernard OA; Berger R; Gilliland DG
Blood; 1998 Jun; 91(12):4419-26. PubMed ID: 9616134
[TBL] [Abstract][Full Text] [Related]
35. Myc is essential for transformation by TEL/platelet-derived growth factor receptor beta (PDGFRbeta).
Bourgeade MF; Défachelles AS; Cayre YE
Blood; 1998 May; 91(9):3333-9. PubMed ID: 9558390
[TBL] [Abstract][Full Text] [Related]
36. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
[TBL] [Abstract][Full Text] [Related]
37. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.
Buijs A; Sherr S; van Baal S; van Bezouw S; van der Plas D; Geurts van Kessel A; Riegman P; Lekanne Deprez R; Zwarthoff E; Hagemeijer A
Oncogene; 1995 Apr; 10(8):1511-9. PubMed ID: 7731705
[TBL] [Abstract][Full Text] [Related]
38. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.
Magnusson MK; Meade KE; Brown KE; Arthur DC; Krueger LA; Barrett AJ; Dunbar CE
Blood; 2001 Oct; 98(8):2518-25. PubMed ID: 11588050
[TBL] [Abstract][Full Text] [Related]
39. Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions.
Heidaran MA; Beeler JF; Yu JC; Ishibashi T; LaRochelle WJ; Pierce JH; Aaronson SA
J Biol Chem; 1993 May; 268(13):9287-95. PubMed ID: 8387491
[TBL] [Abstract][Full Text] [Related]
40. Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling.
Gueller S; Hehn S; Nowak V; Gery S; Serve H; Brandts CH; Koeffler HP
Exp Hematol; 2011 May; 39(5):591-600. PubMed ID: 21310211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
